Drug Approval | November 18, 2021
Zydus Cadila receives U.S.FDA approval for leukaemia injection
Nelarabine is in a class of medications called antimetabolites
Nelarabine is in a class of medications called antimetabolites
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Biocon Biologics and Viatris co-developed the products
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
Following the pre-NDA meeting with the U.S. FDA, the companies confirmed the current efficacy and safety databases are expected to be adequate for filing with confirmed pathways for MDD and PPD
Express Scripts, a leading pharmacy benefit management organization, will list Viatris labelled biosimilar insulin Glargine as a preferred insulin brand on its National Preferred Formulary (NPF)
The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
Subscribe To Our Newsletter & Stay Updated
